<--GAT-->

Veterans With Diabetes Benefit From Lowering Both HbA1c, LDL-C

by U.S. Medicine

February 5, 2016

NEW ORLEANS — Most diabetes patients don’t have levels of glycated hemoglobin (HbA1c) and low-density lipoprotein cholesterol (LDL-C) under control, either individually or in combination, according to a new study seeking to determine the value of dual control as opposed to control of one of the measures.

The study, published recently in the journal Diabetes Therapy, said its goal was to assess the clinical benefits and patient characteristics associated with dual-goal achievement [HbA1c of less than 7% (53 mmol/mol) and LDL-C of less than 100 mg/dL] vs. only LDL-C goal achievement in adults with newly-diagnosed type 2 diabetes.1

To do that, Tulane University-led researchers looked at 16,829 newly diagnosed patients with two or more measures of LDL-C and HbA1c at the South Central VA Health Care Network from January 2004 to June 2010. For the study, the index date was the first HbA1c assessment within three months of the first type 2 diabetes diagnosis.

Results indicated that, compared with LDL-C goal achievement, dual-goal achievement was associated with lower risk of microvascular complications, with a hazard ratio of 0.69, although other outcomes did not differ between those two groups.

With 44.2% of the patients achieving both goals, characteristics associated with that success were prior dual-goal achievement, older age, and use of lipid-lowering drugs.

“Dual-goal achievement in newly diagnosed type 2 diabetes is associated with a lower risk of microvascular complications versus only LDL-C goal achievement,” study authors wrote. “Although dual-goal achievement rates are suboptimal, early and regular intervention will increase its likelihood.”

1.    Shi L, Ye X, Lu M, Wu EQ, Sharma H, Thomason D, Zhang M, Wang Y, Fonseca VA. Glycemic and Cholesterol Control Versus Single-Goal Control in US Veterans with Newly Diagnosed Type 2 Diabetes: A Retrospective Observational Study. Diabetes Ther. 2015 Sep;6(3):339-55. doi: 10.1007/s13300-015-0122-2. Epub 2015 Jul 23. PubMed PMID: 26202185; PubMed Central PMCID: PMC4575310.


Comments are closed here.


Related Articles

Metformin Halves All-Cause Mortality in Frail Older Veterans

Other Important VA Studies at the American Diabetes Association 79th Scientific Sessions MIAMI—The first-line drug of choice for Type 2 diabetes, metformin has long been known to effectively reduce blood glucose levels and substantially cut... View Article

Greatest VA Weight Gains in Women Veterans Without Diabetes

ATLANTA—How does a diagnosis of diabetes affect weight management among U.S. veterans? A study in the journal Obesity (Silver Spring) sought to assess weight trends and diabetes prevalence among U.S. veterans.1 Atlanta VAMC researchers and... View Article


U.S. Medicine Recommends


More From diabetes

Diabetes

Metformin Halves All-Cause Mortality in Frail Older Veterans

Other Important VA Studies at the American Diabetes Association 79th Scientific Sessions MIAMI—The first-line drug of choice for Type 2 diabetes, metformin has long been known to effectively reduce blood glucose levels and substantially cut... View Article

Diabetes

Greatest VA Weight Gains in Women Veterans Without Diabetes

ATLANTA—How does a diagnosis of diabetes affect weight management among U.S. veterans? A study in the journal Obesity (Silver Spring) sought to assess weight trends and diabetes prevalence among U.S. veterans.1 Atlanta VAMC researchers and... View Article

Diabetes

Diabetes Patients Do Well in Military Healthcare-to-VA Transition

SAN DIEGO—When service members leave active duty and receive healthcare in a different setting, care for conditions such as diabetes can suffer. A study in Military Medicine pointed out that changes in healthcare have been... View Article

Diabetes

NPs, PAs Have as Good Diabetes Outcomes as Physicians

DURHAM, NC—So-called physician extenders do as good a job as physicians at the VA in helping to achieve good outcomes in diabetes patients, according to a new study. The report in Annals of Internal Medicine... View Article

Diabetes

Veterans on Standard Diabetes Care Face Dangers from Hypoglycemia Subhead: Post-hoc VADT Analysis Links Low Blood Sugar to CV Events

BALTIMORE, MD—A post-hoc analysis of the Veterans Affairs Diabetes Trial (VADT) once again shines a spotlight on the dangers of hypoglycemia in veterans treated for Type 2 diabetes. The study published in Diabetes Care found... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up